This information is for reference purposes only. It was current when produced and may now be outdated. Archive material is no longer maintained, and some links may not work. Persons with disabilities having difficulty accessing this information should contact us at: https://info.ahrq.gov. Let us know the nature of the problem, the Web address of what you want, and your contact information.
Please go to www.ahrq.gov for current information.
Page 1 of 1
Table 4. Hospitalization, Mortality, and Resource Use over a 1-Year Period for HIV Patients Who Developed PCP
Research in Action, Issue 8
Item
Taking preventive drugs
Yes
No
Number of patients:
Hospitalized
11
54
Had an ICU stay
0
10
Died
0
12
Total hospital days
137
800
ICU days
0
202
Total charges
$95,932
$753,608
Note: ICU—intensive care unit. PCP—Pneumocystis carinii pneumonia.
Source: Gallant JE, McAvinue SM, Moore RD, et al. The impact of prophylaxis on outcome and resource utilization in Pneumocystis carinii pneumonia. Chest 1995; 107:1018-23.
Internet Citation: Table 4. Hospitalization, Mortality, and Resource Use over a 1-Year Period for HIV Patients Who Developed PCP: Research in Action, Issue 8.
September 2002. Agency for Healthcare Research and Quality, Rockville, MD. http://archive.ahrq.gov/research/findings/factsheets/pharmaceutical/rxtherapies/rxriatab4.html
The information on this page is archived and provided for reference purposes only.